Spin-outs at Halfmeyer Ventures
Halfmeyer Ventures is a Berlin-based venture studio and early-stage investor. We back software-led teams at pre-seed and seed with €25,000–€200,000 across health tech, AI, e-commerce, and automation. We invest in corporate spin-outs and academic or research-lab spin-offs when the founding team has clear independence, IP is licensable or assigned to the new entity, and the venture fits our focus sectors. Cold submissions are welcome at halfmeyer.tech/pitch; we respond within 48 hours. This page states how our spin-out engagement model works, what to disclose about parent organizations and IP, and how to pitch us.
The short answer
Founders leaving a company, university, or research lab often ask whether a Berlin studio will engage before every IP clause is settled. Our posture:
- Corporate spin-outs: welcome when the team can operate independently of the parent and the product fits our software-led sectors.
- Academic or research-lab spin-offs: welcome on the same independence and sector bar, with IP that is licensable or assigned to the new company.
- What we need in the deck: parent organization, IP ownership, what stays with the lab or corporate, and licensing or governance terms stated clearly enough for a first-pass review.
- Ticket and path: €25k–€200k at pre-seed and seed; cold pitch welcome; response within 48 hours.
This is our investment posture, not legal advice on how to license IP or structure a technology-transfer deal. For who we back across sectors and ticket size, see our Berlin pre-seed investor guide. For stage proof, see what pre-seed means.
Corporate spin-outs
A corporate spin-out is a new company that leaves a parent organization with people, technology, or both. We engage when the founding team has clear independence: decision rights on product and hiring, ability to raise and close a round into the new entity, and a path that is not blocked by parent vetoes on ordinary operating choices. Parent equity, transition agreements, or ongoing commercial relationships can still exist; what we need is a company that can ship as a startup, not as a captive project.
Software-led fit still applies. We look for category-defining technology in health tech, AI, e-commerce, or automation, or an adjacent vertical where software, data, or automation is the product core. We typically pass on capital-intensive hardware-only or deep-tech bets without a software surface. If the spin-out is mostly a cost-center carve-out with no independent product roadmap, that is usually a pass for investment. For the full criteria set, see what we look for.
Academic and research-lab spin-offs
Academic and research-lab spin-offs start in a university, institute, or lab and move into a new company. We back those companies when the founding team can operate independently and when IP is licensable or assigned to the new entity. We do not need every patent family perfected before you submit, but we do need a clear picture of who owns what, what the company can commercialize, and what remains with the institution.
The investment bar does not relax because the science is strong. Pre-seed and seed investment still requires a working product, prototype, or validated problem–solution fit. Idea-only decks without that proof are usually a pass for investment; advisory and incubation can start earlier. Software surface matters here too: a research thesis without a product path into our sectors is not enough. For how investment differs from incubation and advisory, see invest vs incubate vs accelerate vs advisory.
Independence and IP we need to see
Independence and IP clarity are the two gates that make a spin-out investable for us. Independence means the founding team can prioritize the company, hire, sell, and raise without needing parent approval for ordinary decisions. IP clarity means the company can use the technology it is building on: through a license that supports commercialization, or through assignment into the new entity, with a plain statement of what stays with the lab or corporate.
We are not a technology-transfer office and we do not negotiate licensing frameworks for you. We need enough disclosure to decide whether diligence can proceed. If IP ownership is unknown, contested, or locked so the company cannot ship or raise, we will pass or ask clarifying questions before scheduling a call. If licensing is in progress, say so and name the status. For jurisdiction and entity structure around the new company, see incorporation and jurisdiction.
What to disclose in the deck
Clarity on parent and IP helps us respond within the 48-hour window. In your first-pass deck, include:
- Parent organization: company, university, institute, or lab the venture spun from, and the relationship today.
- Independence: who controls product, hiring, and fundraising in the new entity; any parent vetoes or reserved matters that still matter.
- IP ownership: what is licensed, assigned, or still owned by the parent or lab; what the company can commercialize.
- What stays behind: technology, data, trademarks, or people that remain with the parent or institution.
- Licensing or governance terms: exclusivity if known, equity or royalty hooks that affect the round, and any governance rights the parent or institution retains.
- Round structure: amount, use of funds, timing, proposed instrument, and any committed co-investors.
You do not need a full legal data room on first submit. Ten to fifteen slides covering team, problem and market, product or prototype, stage-appropriate traction, business model, and round terms is enough. Set the link to view-only for anyone with the link. For slide mechanics, see pitch deck expectations. For lead and co-invest posture, see co-investment at Halfmeyer.
How this fits investment, incubation, and advisory
Most spin-out pitches we see aim at investment: a €25k–€200k check at pre-seed or seed with design, engineering, and go-to-market support beyond the capital. That path still needs stage proof and software-led sector fit. If the company is earlier (clear IP path forming, but product still thin), incubation or advisory may fit better than a check. Acceleration is for existing startups that need embedded senior product or engineering help. Name the engagement model in the deck so we route the conversation correctly.
Public track record we state for the entity: 20+ investments, 5.6× portfolio ROI, and 100+ products built. Those are entity facts, not a claim that every portfolio company was a spin-out or that every spin-out closes. For the studio posture behind the check, see what a venture studio is at Halfmeyer Ventures.
How to pitch a spin-out
Submit at halfmeyer.tech/pitch. Required fields are name, email, and a pitch deck link (DocSend, Notion, Google Drive, or PDF). Company name is optional. Cold submissions are welcome; you do not need a warm introduction from a technology-transfer office, corporate BD, or mutual connection. State sector fit, parent and IP facts, independence, and whether you want investment, incubation, acceleration, or advisory.
We review every deck personally and respond within 48 hours with a founder call path, clarifying questions by email, or a clear pass. After a productive call, diligence typically runs one to two weeks and stays lean at pre-seed and seed. We do not give legal advice on licensing, assignment, or parent negotiations. Our job here is to state whether a corporate or academic spin-out can pitch Halfmeyer Ventures with a fair shot at review: yes, when independence, IP clarity, and sector fit are in place. For the cold path end to end, see how to pitch Halfmeyer. For founder commitment norms (solo, part-time, repeat), see solo, part-time, and repeat founders.
Submit your deck
If you are spinning out of a company, university, or research lab and want a Berlin venture studio that pairs a €25k–€200k check with design, engineering, and GTM support when independence and IP are clear, submit your deck. Halfmeyer Ventures responds within 48 hours.